Dr Reddys Laboratories launches Clofarabine Injection
In United States market
Dr Reddys Laboratories announced that it has launched Clofarabine Injection, a therapeutic equivalent generic version of Clolar (clofarabine) Injection in the United States market, approved by the USFDA.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content